跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,693 条关于
“Mitsubishi Corporation”
全部
1,693
临床试验
134
药物
115
机构
469
资讯
975
10个月前
Wheeler Bio Partners with Mitsubishi Corporation to Expand AI-Enabled Biomanufacturing Platform Across Asia-Pacific
去年
Mitsubishi Tanabe Pharma America to Present Breakthrough Neurodegenerative Disease Research at AAN 2025
去年
Dewpoint and Mitsubishi Tanabe Partner to Develop ALS Drug Targeting Biomolecular Condensates
去年
GV20 Therapeutics Partners with Mitsubishi Tanabe to Develop Novel AI-Discovered Antibody-Drug Conjugates
去年
Mitsubishi Tanabe Pharma America Presents ND0612 Data for Parkinson's Disease at PSG Meeting
11个月前
Mitsubishi Tanabe Pharma to Present Phase 3 Data on Continuous Levodopa Infusion ND0612 for Parkinson's Disease
去年
Real-World Data Analysis Shows Edaravone Associated with Longer Milestone-Free Time in ALS
去年
SparX Biopharmaceutical and Mitsubishi Tanabe Pharma America Partner on Novel Immune Cell-Targeting ADC Program
去年
Edaravone Shows Promise in Targeting TDP-43 Mislocalization in ALS, New Preclinical Research Reveals
去年
ND0612 Infusion Shows Sustained Reduction in Off-Time for Parkinson's Patients
第 1 页,共 98 页
上一页
下一页